Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
VELINDRE NHS TRUST TRUST BOARD REPORT 5th December 2013 Meeting Date: Agenda Item: Report Author: Executive Sponsor: Presented by: Ashleigh O’Callaghan, Support Manager, Cancer Services Simon Dean, Chief Executive Andrea Hague, Director of Velindre Cancer Centre Velindre Cancer Centre Annual Report 2013 ACRONYMS MDT – Multi Disciplinary Team SBRT – Stereotactic Body Radiotherapy 1. PURPOSE & ACTION REQUIRED The Trust Board is requested to approve the Velindre Cancer Annual Report 2013 (attached). 2. INTRODUCTION In 2012, the Minister for Health and Social Services launched ‘Together Against Cancer – A Cancer Delivery Plan’, which outlined what people can expect from cancer care by 2016. www.wales.gov.uk/topics/health/publications/health/strategies/cancer/?lang=eng The key message in the document is that Wales should aim to be amongst the best in Europe’ for cancer treatment and outcomes. It aims to achieve this through the following domains: Meeting people’s needs (Person Centred Care) Focus on preventing cancer and early detection Delivery fast, effective treatment and care Improving information Caring at the end of life Targeting Research The Plan provides a framework for action by Health Boards and Trusts by setting out Welsh Government’s expectation of NHS in Wales to tackle cancer: People of all ages to have a minimised risk of developing cancer and where it does occur, an excellent chance of surviving, wherever they live in Wales Wales to have cancer incidence, mortality and survival rates comparable with the best in Europe Using the following indicators to measure success: • Cancer incidence rates (European Age Standardised Rates) • Cancer mortality rates (European Age Standardised Rates) • 1 and 5 year cancer survival rates 3. CONSIDERATIONS FOR BOARD/COMMITTEE In addition to national reporting, Together for Health - A Cancer Delivery Plan was designed as a framework for the individual Health Boards to be held to account on the outcomes they deliver for their populations through the planning innovation and delivery of high quality, effective services in partnership. Velindre NHS Trust, as it is not responsible for a local population, has not been specifically asked to produce a cancer annual report, but the Division has decided to develop its own annual cancer report for applicable outcomes (see attached). The template of the report is prescribed by Welsh Government, and the Cancer Centre are asked to include specific information under each of the domains mentioned within the section above – thus, this report is not designed as a comprehensive report of the Cancer Centre itself, but a report outlining progress against the domains within the WG “Together Against Cancer’ strategy. This year, Velindre Cancer Centre has have been able to demonstrate progress in most of these areas e.g. development of acute oncology services and partnership with 1000 lives; measurable positive improvements to patient pathways through the Velindre Improvement Programme; development of MDT for metastatic breast cancer; Macmillan funding for Beyond Breast Cancer Project on improving breast follow up; good uptake of clinical trials and opening of phase 1 trials unit; pilot of holistic needs assessment; funding for SBRT; development of a system to regularly review deaths within 30 days of chemotherapy treatment. Continued progress and success with achievement of the targets is dependent upon Velindre Cancer Centre working closely with Health Boards across the patient pathway for example, to achieve tissue collection targets, recruit patients into trials and to improve outcomes. This report has been considered by the Trust Executive Management Board, Planning and Performance Management committees, who have endorsed it for approval by the Trust Board. 4. ACTIONS/RECOMMENDATION TO THE BOARD/COMMITTEE The Board are asked to APPROVE the Velindre Cancer Annual Report.